Co-Diagnostics EBIT Margin 2017-2025 | CODX

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Co-Diagnostics (CODX) over the last 10 years. The current EBIT profit margin for Co-Diagnostics as of March 31, 2025 is .
Co-Diagnostics EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2025-03-31 $0.00B $-0.04B -975.00%
2024-12-31 $0.00B $-0.04B -1000.00%
2024-09-30 $0.01B $-0.04B -500.00%
2024-06-30 $0.01B $-0.04B -433.33%
2024-03-31 $0.01B $-0.04B -716.67%
2023-12-31 $0.01B $-0.04B -614.29%
2023-09-30 $0.00B $-0.06B -1425.00%
2023-06-30 $0.01B $-0.06B -785.71%
2023-03-31 $0.01B $-0.05B -391.67%
2022-12-31 $0.03B $-0.03B -79.41%
2022-09-30 $0.05B $0.01B 16.98%
2022-06-30 $0.08B $0.03B 38.46%
2022-03-31 $0.10B $0.05B 46.00%
2021-12-31 $0.10B $0.05B 47.42%
2021-09-30 $0.10B $0.05B 50.00%
2021-06-30 $0.10B $0.05B 52.08%
2021-03-31 $0.09B $0.05B 56.99%
2020-12-31 $0.08B $0.04B 56.00%
2020-09-30 $0.05B $0.02B 50.00%
2020-06-30 $0.03B $0.01B 38.46%
2020-03-31 $0.00B $-0.01B -300.00%
2019-12-31 $0.00B $-0.01B 0.00%
2019-09-30 $0.00B $-0.01B 0.00%
2019-06-30 $0.00B $-0.01B 0.00%
2019-03-31 $0.00B $-0.01B 0.00%
2018-12-31 $0.00B $-0.01B 0.00%
2018-09-30 $0.00B $-0.01B 0.00%
2018-06-30 $0.00B $-0.01B 0.00%
2018-03-31 $0.00B $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.127B 26.17
CVS Health (CVS) United States $79.026B 9.85
Elevance Health (ELV) United States $61.847B 8.32
Cencora (COR) United States $55.889B 19.44
DiDi Global (DIDIY) China $23.438B 24.90
Labcorp Holdings (LH) United States $21.888B 17.27
Natera (NTRA) United States $18.376B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.072B 0.00
ICON (ICLR) Ireland $13.441B 12.93
CochLear (CHEOY) Australia $13.183B 0.00
Solventum (SOLV) United States $12.410B 13.14
Medpace Holdings (MEDP) United States $11.886B 31.46
Revvity (RVTY) United States $10.400B 18.04
Viatris (VTRS) United States $10.340B 3.55
Sonic Healthcare (SKHHY) Australia $8.699B 0.00
Charles River Laboratories (CRL) United States $8.198B 16.06
HealthEquity (HQY) United States $7.874B 34.49
Avantor (AVTR) United States $7.741B 11.36
Caris Life Sciences,�Inc (CAI) United States $7.133B 0.00
Bausch + Lomb (BLCO) Canada $4.776B 32.14
Amplifon S.p.A (AMFPF) Italy $3.890B 21.30
BrightSpring Health Services (BTSG) United States $3.453B 26.54
Sotera Health (SHC) United States $3.165B 17.98
GeneDx Holdings (WGS) United States $2.899B 66.84
Surgery Partners (SGRY) United States $2.727B 35.47
Alignment Healthcare (ALHC) United States $2.568B 0.00
Organon (OGN) United States $2.535B 2.69
Concentras Parent (CON) United States $2.497B 14.43
Progyny (PGNY) United States $1.928B 42.43
Premier (PINC) United States $1.751B 13.29
PACS (PACS) United States $1.618B 0.00
GoodRx Holdings (GDRX) United States $1.618B 32.36
Ardent Health (ARDT) United States $1.462B 6.23
Teladoc Health (TDOC) United States $1.226B 0.00
Establishment Labs Holdings (ESTA) $1.195B 0.00
Pediatrix Medical (MD) United States $1.029B 7.83
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.882B 302.50
Agilon Health (AGL) United States $0.704B 0.00
AMN Healthcare Services Inc (AMN) United States $0.683B 6.40
CareDx (CDNA) United States $0.680B 10.63
Performant Healthcare (PHLT) United States $0.598B 0.00
Embecta (EMBC) United States $0.582B 3.92
Nutex Health (NUTX) United States $0.467B 7.06
Auna S.A (AUNA) Luxembourg $0.457B 10.28
LifeMD (LFMD) United States $0.452B 0.00
Sonida Senior Living (SNDA) United States $0.451B 0.00
Omada Health (OMDA) $0.448B 0.00
So-Young (SY) China $0.438B 0.00
SBC Medicals (SBC) United States $0.433B 0.00
InnovAge Holding (INNV) United States $0.423B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.406B 0.00
Oncology Institute (TOI) United States $0.333B 0.00
Enhabit (EHAB) United States $0.330B 27.17
Beauty Health (SKIN) United States $0.193B 0.00
DocGo (DCGO) United States $0.136B 22.17
Sera Prognostics (SERA) United States $0.102B 0.00
Ascend Wellness Holdings (AAWH) United States $0.080B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.053B 0.00
KindlyMD (NAKA) United States $0.046B 0.00
ModivCare (MODV) United States $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
Basel Medical Group (BMGL) Singapore $0.037B 0.00
OSR Holdings (OSRH) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Pheton Holdings (PTHL) China $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00